Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.

TitleSerum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Publication TypeJournal Article
Year of Publication2006
AuthorsRip, J, Nierman, MC, Wareham, NJ, Luben, R, Bingham, SA, Day, NE, van Miert, JNI, Hutten, BA, Kastelein, JJP, Kuivenhoven, JAlbert, Khaw, K-T, S Boekholdt, M
JournalArterioscler Thromb Vasc Biol
Volume26
Issue3
Pagination637-42
Date Published2006 Mar
ISSN1524-4636
KeywordsAged, Biological Markers, Case-Control Studies, Cholesterol, HDL, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Lipoprotein Lipase, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Triglycerides
Abstract

BACKGROUND: Lipoprotein lipase (LPL) is associated with coronary artery disease (CAD) risk, but prospective population data are lacking. This is mainly because of the need for cumbersome heparin injections, which are necessary for LPL measurements. Recent retrospective studies, however, indicate that LPL concentration can be reliably measured in serum that enabled evaluation of the prospective association between LPL and future CAD.

METHODS AND RESULTS: LPL concentration was determined in serum samples of men and women in the EPIC-Norfolk population cohort who developed fatal or nonfatal CAD during 7 years of follow-up. For each case (n=1006), 2 controls, matched for age, sex, and enrollment time, were identified. Serum LPL concentration was lower in cases compared with controls (median and interquartile range: 61 [43-85] versus 66 [46-92] ng/mL; P

CONCLUSIONS: Reduced levels of serum LPL are associated with an increased risk for future CAD. The data suggest that high LPL concentrations may be atheroprotective through decreasing TG levels and increasing HDL-C levels.

DOI10.1161/01.ATV.0000201038.47949.56
Alternate JournalArterioscler. Thromb. Vasc. Biol.
Citation Key10.1161/01.ATV.0000201038.47949.56
PubMed ID16373616
Grant ListG0401527 / / Medical Research Council / United Kingdom
MC_U106179471 / / Medical Research Council / United Kingdom
/ / Wellcome Trust / United Kingdom